$4.340
+0.010 (+0.23%)At close
HHS News
HHS Events
Harte Hanks Inc Trading Resumes
Harte Hanks Inc trading resumes
Star Equity to Acquire Harte Hanks for $5.00 per Share
Harte Hanks to be acquired by Star Equity for $5.00 per share
Harte Hanks appoints David Fisher as president
Harte Hanks announced the appointment of David Fisher as President. This leadership transition comes at a strategically significant time, as the Company advances its transformation initiatives, deepens its commitment to delivering long-term client value, and positions itself to drive sustained EBITDA growth. Fisher initially joined Harte Hanks in March 2023 as a strategic development advisor focused on identifying operational inefficiencies and unlocking growth across business segments. On January 29, 2024, he was named Chief Transformation Officer and launched 'Project Elevate,' a company-wide initiative driving EBITDA stability, service innovation, and execution discipline. Recognizing his performance and vision, the Company appointed him Interim COO on January 28, 2025, to oversee enterprise alignment during a pivotal transition period. In his new role, Mr. Fisher will lead day-to-day operations and drive strategic execution in partnership with Harte Hanks' executive leadership team.
Harte Hanks extends line of credit with Texas Capital Bank
Harte Hanks has extended its $25M secured revolving line of credit with Texas Capital Bank for an additional three-year term beyond its original maturity date of June 30. The amended agreement, now maturing at the end of June 2028, strengthens the Company's financial flexibility and supports the long-term operational stability of the Company. The Second Amendment also includes an accordion feature that allows Harte Hanks to seek up to a $10M increase in commitments under the credit line, subject to lender approval. The expanded credit facility will be used to fund working capital, accelerate innovation, and support strategic growth initiatives across the Company's business segments.
Harte Hanks acquires exclusive rights to license ADS' Medical Ailment Database
Harte Hanks has obtained exclusive rights to license ADS Data Direct's Medical Ailment Database, with limited client exceptions. The company said, "This transformative undertaking positions Harte Hanks as the controller of one of the most comprehensive, HIPAA-compliant health data assets available in the market, delivering unmatched value to healthcare marketers." ADS's Medical Ailment Database, sourced through the Healthier Me Today platform, provides access to 100% triple opt-in consumers who have self-identified as living with specific health conditions across more than 200 ailment categories. This valuable data asset enhances Harte Hanks' ability to deliver superior targeting precision, campaign performance, and compliance assurance for clients in the pharmaceutical, medical device, and broader healthcare sectors.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.